Cuba's domestically developed COVID-19 vaccine Abdala showed a 100% efficacy rate in preventing death and serious condition during its third phase of trials, the vaccine developer, the Center for Genetic Engineering and Biotechnology (CIGB), said.
from Google Alert - health https://ift.tt/3ikdtkp
via IFTTT
0 comments:
Post a Comment